Jane Street Group LLC Acquires 32,091 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Jane Street Group LLC boosted its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 1,390.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,399 shares of the medical instruments supplier's stock after buying an additional 32,091 shares during the period. Jane Street Group LLC owned about 0.63% of Mesa Laboratories worth $4,536,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of MLAB. Barclays PLC raised its stake in Mesa Laboratories by 357.4% during the third quarter. Barclays PLC now owns 8,837 shares of the medical instruments supplier's stock worth $1,148,000 after acquiring an additional 6,905 shares in the last quarter. Franklin Resources Inc. grew its stake in Mesa Laboratories by 27.8% during the third quarter. Franklin Resources Inc. now owns 6,444 shares of the medical instruments supplier's stock worth $828,000 after buying an additional 1,403 shares during the last quarter. JPMorgan Chase & Co. grew its stake in Mesa Laboratories by 29.3% during the third quarter. JPMorgan Chase & Co. now owns 8,406 shares of the medical instruments supplier's stock worth $1,092,000 after buying an additional 1,906 shares during the last quarter. Pacer Advisors Inc. grew its stake in Mesa Laboratories by 4.3% during the fourth quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier's stock worth $231,000 after buying an additional 73 shares during the last quarter. Finally, Berry Wealth Group LP grew its stake in Mesa Laboratories by 5.3% during the fourth quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier's stock worth $219,000 after buying an additional 83 shares during the last quarter. Institutional investors and hedge funds own 90.60% of the company's stock.

Insiders Place Their Bets

In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of the business's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total value of $2,602,110.00. Following the completion of the transaction, the chief executive officer now directly owns 43,337 shares of the company's stock, valued at approximately $5,369,887.67. The trade was a 32.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 4.40% of the company's stock.

Mesa Laboratories Price Performance

Mesa Laboratories stock traded down $0.70 during trading hours on Friday, hitting $120.66. 17,722 shares of the stock were exchanged, compared to its average volume of 39,680. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71. The stock has a market capitalization of $655.64 million, a P/E ratio of -2.61 and a beta of 0.97. Mesa Laboratories, Inc. has a 12 month low of $83.68 and a 12 month high of $155.12. The business's 50-day moving average is $118.37 and its two-hundred day moving average is $126.59.

Mesa Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 30th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date is Friday, May 30th. Mesa Laboratories's dividend payout ratio is currently -1.38%.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.